FDA Advises Careful Planning Of Device Animal Studies
This article was originally published in The Gray Sheet
The agency issued draft guidance on deciding when to conduct and how to design medical device animal studies to appropriately assess risk in advance of testing in humans. Starting on preclinical testing without a clear understanding of FDA expectations can be a costly route, agency officials say.
Register for our free email digests: